SummitTX Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Buy
+2,578
New +$1.24M 0.03% 411
2026
Q1
Sell
-2,145
Closed -$1.24M 970
2025
Q4
$1.24M Sell
2,145
-5,667
-73% -$3.2M 0.04% 381
2025
Q3
$3.79M Sell
7,812
-148
-2% -$68.9K 0.16% 146
2025
Q2
$3.23M Buy
+7,960
New +$3.33M 0.14% 177

Other funds holding TMO

SummitTX Capital's TMO Position: Q2 2026 in Review

SummitTX Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 2,578 shares worth $1.29M. The stake represents 0.03% of the portfolio and ranks #411 among its holdings. This is a return to the name: SummitTX Capital previously reported a position in TMO as recently as Q4 2025.

SummitTX Capital first reported a position in TMO in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.79M in Q3 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • SummitTX Capital held 2,578 shares of Thermo Fisher Scientific worth $1.29M as of Q2 2026.
  • Thermo Fisher Scientific was a new SummitTX Capital position in Q2 2026.
  • Thermo Fisher Scientific made up 0.03% of SummitTX Capital's portfolio in Q2 2026, its #411 holding.
  • SummitTX Capital first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 4 quarters since.
  • SummitTX Capital's Thermo Fisher Scientific position peaked at $3.79M in Q3 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.